Araris Biotech AG
Edit

Araris Biotech AG

https://ararisbiotech.com/
Last activity: 06.03.2024
Categories: HealthTechMedTechPlatformTechnologyBioTechBuildingDrugEngineering
Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich focusing on the commercialization of a novel antibody-drug conjugate (ADC)-linker technology. Araris' innovative platform allows for the attachment of any payload to "off the shelf" antibodies without the need of prior antibody engineering in one-step. The resulting ADCs have a well-defined drug-to-antibody ratio, are stable and monomeric. All these favorable properties contribute to the high efficacy, stability and low level of toxicity observed so far. In summary, the straightforward drug conjugation, versatility of the technology and high in vivo efficacy enable the generation of ADC compounds for the treatment of patients with a high unmet medical need.
Mentions
37
Location: Switzerland, Zurich
Total raised: $46.11M
Twitter
LinkedIn
Email

Investors 4

Funding Rounds 4

DateSeriesAmountInvestors
05.05.2023Grant$2.8M-
05.10.2022-$24M-
22.10.2020Seed$16.75M-
20.08.2019Seed$2.56M-

Mentions in press and media 37

DateTitleDescriptionSource
06.03.2024Araris Biotech AG to Present Data on Antibody-Drug Conjugate...-globenewsw...
12.11.2023Araris Biotech AG Announces Research Collaboration with Taih...AU ZH, SWITZERLAND, November 8, 2023 – Araris Biotech AG (“Araris”), a Swiss oncology biotech compan...4biocapita...
08.11.2023Araris to develop drug candidates for Japanese pharma compan...startuptic...
09.10.2023Industry veterans take on executive roles in startupsstartuptic...
19.05.2023Cash and honorary awards for Swiss innovatorsstartuptic...
05.05.2023Araris Biotech Receives CHF 2.5M Grant FundingAraris Biotech AG, a Swiss company pioneering proprietary antibody-drug conjugate (ADC)-linker techn...finsmes.co...
05.05.2023Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator ...-globenewsw...
28.04.2023Swiss Accelerator: Innosuisse supports 53 companies with CHF...startuptic...
18.04.2023Araris expands its pipeline towards solid tumor indicationsstartuptic...
14.04.2023Araris Biotech AG Presents Preclinical Data Highlighting Sta...AU ZH, Switzerland, April 14, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a pro...einpresswi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In